AVNS - Avanos Medical Inc
Close
24.22
0.080 0.330%
Share volume: 204,848
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Surgical Appliance and Supplies Manufacturing :
-12.02%
PREVIOUS CLOSE
CHG
CHG%
$24.14
0.08
0.33%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-21 | 2023-05-03 | 2023-08-09 | 2023-11-01 | 2024-02-21 | 2024-05-02 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 1.775 B | 1.787 B | 1.735 B | 1.667 B | 1.725 B | 1.692 B | 1.661 B | 1.658 B | |
| Current Assets | 470.000 M | 499.800 M | 453.800 M | 506.900 M | 524.600 M | 487.000 M | 467.800 M | 474.100 M | |
| Inventories | 193.600 M | 190.300 M | 200.000 M | 148.300 M | 156.600 M | 163.200 M | 165.600 M | 163.900 M | |
| Other Current Assets | 13.200 M | 13.900 M | 15.400 M | 15.800 M | 13.600 M | 28.800 M | 28.600 M | 22.300 M | |
| Short Term Investments | 13.200 M | 13.900 M | 15.400 M | 15.800 M | 13.600 M | 28.800 M | 28.600 M | 22.300 M | |
| Total Receivables | 146.200 M | 167.900 M | 142.700 M | 152.300 M | 145.200 M | 142.800 M | 131.300 M | 123.000 M | |
| Current Cash | 117.000 M | 127.700 M | 95.700 M | 81.800 M | 107.100 M | 87.700 M | 75.800 M | 92.200 M | |
| Total Non-current Assets | 1.305 B | 1.287 B | 1.281 B | 1.160 B | 1.200 B | 1.205 B | 1.194 B | 1.184 B | |
| Property Plant Equipment | 163.400 M | 163.900 M | 163.500 M | 122.600 M | 116.800 M | 117.200 M | 116.200 M | 110.700 M | |
| Other Assets | 16.100 M | 17.600 M | 18.600 M | 18.500 M | 18.400 M | 19.300 M | 19.100 M | 16.700 M | |
| Intangible Assets | 258.700 M | 251.000 M | 244.700 M | 222.600 M | 242.200 M | 239.500 M | 232.800 M | 226.200 M | |
| Goodwill | 823.600 M | 819.400 M | 821.500 M | 762.600 M | 791.500 M | 796.100 M | 794.900 M | 794.400 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.775 B | 1.787 B | 1.735 B | 1.667 B | 1.725 B | 1.692 B | 1.661 B | 1.658 B | |
| Total liabilities | 511.700 M | 495.700 M | 436.200 M | 431.900 M | 502.800 M | 456.100 M | 433.400 M | 435.800 M | |
| Total current liabilities | 162.300 M | 185.800 M | 158.500 M | 160.500 M | 170.700 M | 234.600 M | 205.200 M | 208.200 M | |
| Accounts Payable | 62.700 M | 67.900 M | 59.600 M | 65.400 M | 52.100 M | 56.300 M | 57.000 M | 51.400 M | |
| Other liabilities | 27.800 M | 23.500 M | 15.500 M | 15.400 M | 15.600 M | 10.000 M | 10.800 M | 10.500 M | |
| Current long term debt | 6.200 M | 6.200 M | 6.200 M | 6.200 M | 6.200 M | 8.600 M | 9.400 M | 10.200 M | |
| Long term debt | 247.800 M | 226.300 M | 204.700 M | 203.300 M | 258.300 M | 159.400 M | 167.200 M | 164.900 M | |
| Other liabilities | 27.800 M | 23.500 M | 15.500 M | 15.400 M | 15.600 M | 10.000 M | 10.800 M | 10.500 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.264 B | 1.291 B | 1.299 B | 1.235 B | 1.222 B | 1.236 B | 1.228 B | 1.222 B | |
| Common stock | 46.600 M | 46.400 M | 46.600 M | 46.800 M | 46.800 M | 46.200 M | 46.200 M | 45.900 M | |
| Retained earnings | -270.000 M | -253.100 M | -253.600 M | -321.700 M | -325.400 M | -314.900 M | -315.800 M | -314.000 M |